Aspira Pathlab & Diagnostics Ltd - 540788 - Closure of Trading Window
Intimation of the Closure of Trading Window for the declaration of Unaudited Financial Results for the quarter ended June 30, 202429-06-2024
29-06-2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Enclosed herewith Form C received from Mr.Jay Bhanushali, Promoter & Director Immediate Relative of the Company for the acquisition of Equity Shares from the market as on June 28, 2024.29-06-2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Enclosed herewith Form C received from Mrs. Shraddha Bhanushali, Director & Promoters Immediate Relative of the Company for the acquisition of Equity Shares from the market as on June 28, 2024.29-06-2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Enclosed herewith Form C received from Mr. Nikunj Velji Mange, Executive Director (08489442) of the Company for the acquisition of Equity Shares from the market as on June 28, 2024.29-06-2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Reminder To Update KYC Details Pursuant To SEBI Circulars
Reminder to the Holders of the Physical Securities to furnish PAN, KYC Details and Nomination as per SEBI Circular.08-06-2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of the Financial Results for the quarter & financial year ended March 31, 2024.30-05-2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Enclosed herewith Annual Secretarial Compliance Report for the Financial Year Ended March 31, 2024.29-05-2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Intimation For The Appointment Of Secretarial Auditor And Internal Auditor Of The Company
Appointment of Secretarial Auditor & Internal Auditor of the Company for the Financial Year 2024-202528-05-2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Outcome for For The Quarter And The Financial Year Ended March 31, 2024
Audited Financial Results for the quarter and Financial Year ended March 31, 202428-05-2024
Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for To Consider And Approve Audited Financial Statements Of The Company As On March 31, 2024 And To Discuss Any Other Matter With The Permission Of The Chair.
Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve Audited Financial Statements (Standalone) of the Company for the fourth quarter and year ended as on March 31, 2024 and to discuss any other matter with the permission of the Chair.18-05-2024